The Hfn4 gene activates hepatic gluconeogenesis [25], confirming the downregulation of glycolysis, and triggers insulin genes both directly and indirectly [26,27], regulating genes involved in the progression of NAFLD [28]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.